These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 28593575

  • 1. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
    Fortunato A.
    Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
    [Abstract] [Full Text] [Related]

  • 2. The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells.
    Pillozzi S, D'Amico M, Bartoli G, Gasparoli L, Petroni G, Crociani O, Marzo T, Guerriero A, Messori L, Severi M, Udisti R, Wulff H, Chandy KG, Becchetti A, Arcangeli A.
    Br J Cancer; 2018 Jan; 118(2):200-212. PubMed ID: 29161243
    [Abstract] [Full Text] [Related]

  • 3. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
    Chen QY, Jiao DM, Wang J, Hu H, Tang X, Chen J, Mou H, Lu W.
    Oncotarget; 2016 Apr 26; 7(17):24510-26. PubMed ID: 27014910
    [Abstract] [Full Text] [Related]

  • 4. Down-regulation of aquaporin 5-mediated epithelial-mesenchymal transition and anti-metastatic effect by natural product Cairicoside E in colorectal cancer.
    Chen C, Ma T, Zhang C, Zhang H, Bai L, Kong L, Luo J.
    Mol Carcinog; 2017 Dec 26; 56(12):2692-2705. PubMed ID: 28833571
    [Abstract] [Full Text] [Related]

  • 5. Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer.
    Fan LC, Teng HW, Shiau CW, Tai WT, Hung MH, Yang SH, Jiang JK, Chen KF.
    Oncotarget; 2016 Sep 27; 7(39):64136-64147. PubMed ID: 27580057
    [Abstract] [Full Text] [Related]

  • 6. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H, Yang X, Guo Y, Shui L, Li S, Bai Y, Liu Y, Zeng M, Xia J.
    J Exp Clin Cancer Res; 2019 Jul 22; 38(1):324. PubMed ID: 31331361
    [Abstract] [Full Text] [Related]

  • 7. Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer.
    Min J, Liu L, Li X, Jiang J, Wang J, Zhang B, Cao D, Yu D, Tao D, Hu J, Gong J, Xie D.
    Sci Rep; 2015 Nov 13; 5():16578. PubMed ID: 26564738
    [Abstract] [Full Text] [Related]

  • 8. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
    Toden S, Okugawa Y, Jascur T, Wodarz D, Komarova NL, Buhrmann C, Shakibaei M, Boland CR, Goel A.
    Carcinogenesis; 2015 Mar 13; 36(3):355-67. PubMed ID: 25653233
    [Abstract] [Full Text] [Related]

  • 9. Nuclear factor I/B promotes colorectal cancer cell proliferation, epithelial-mesenchymal transition and 5-fluorouracil resistance.
    Liu Z, Chen J, Yuan W, Ruan H, Shu Y, Ji J, Wu L, Tang Q, Zhou Z, Zhang X, Cheng Y, He S, Shu X.
    Cancer Sci; 2019 Jan 13; 110(1):86-98. PubMed ID: 30320939
    [Abstract] [Full Text] [Related]

  • 10. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X, Wu J, Pan C, Wang H, Ying X, Zhou Y, Yu H, Zuo Y, Pan Z, Liu RY, Huang W.
    Gastroenterology; 2013 Aug 13; 145(2):426-36.e1-6. PubMed ID: 23583431
    [Abstract] [Full Text] [Related]

  • 11. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
    Chen J, Yuan W, Wu L, Tang Q, Xia Q, Ji J, Liu Z, Ma Z, Zhou Z, Cheng Y, Shu X.
    Oncotarget; 2017 Feb 07; 8(6):9961-9973. PubMed ID: 28035069
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers.
    Pillozzi S, Masselli M, De Lorenzo E, Accordi B, Cilia E, Crociani O, Amedei A, Veltroni M, D'Amico M, Basso G, Becchetti A, Campana D, Arcangeli A.
    Blood; 2011 Jan 20; 117(3):902-14. PubMed ID: 21048156
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S, Gonugunta VK, Penugurti V, Malisetty VL, Vadlamudi RK, Manavathi B.
    Cell Oncol (Dordr); 2017 Apr 20; 40(2):133-144. PubMed ID: 28039608
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways.
    Zhou ZP, Wang LP, Hong ZS, Qiu CZ, Wang MZ, Chen ZX, Tang LF, Yu WS, Wang CX.
    Int J Oncol; 2018 Sep 20; 53(3):1183-1192. PubMed ID: 30015866
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.
    Shao Q, Zhang P, Ma Y, Lu Z, Meng J, Li H, Wang X, Chen D, Zhang M, Han Y, Liu H, Ma S.
    Gene; 2018 Apr 30; 652():48-58. PubMed ID: 29427737
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Luteolin inhibits colorectal cancer cell epithelial-to-mesenchymal transition by suppressing CREB1 expression revealed by comparative proteomics study.
    Liu Y, Lang T, Jin B, Chen F, Zhang Y, Beuerman RW, Zhou L, Zhang Z.
    J Proteomics; 2017 May 24; 161():1-10. PubMed ID: 28391045
    [Abstract] [Full Text] [Related]

  • 20. Trifluoperazine as an alternative strategy for the inhibition of tumor growth of colorectal cancer.
    Qian K, Sun L, Zhou G, Ge H, Meng Y, Li J, Li X, Fang X.
    J Cell Biochem; 2019 Sep 24; 120(9):15756-15765. PubMed ID: 31081173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.